STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

MARPAI ANNOUNCES 2026 MOMENTUM AND KEY PARTNERSHIP EXPANSION

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
partnership

Marpai (OTCQX: MRAI) announced renewal of its access to the Aetna Signature Administrator (ASA) PPO network and integration of the Aetna Faircost Optimizer, while reporting a better-than-expected 2026 sales cycle with new clients effective January 1, 2026. The ASA renewal preserves broad national provider access and competitive network discounts for Marpai's self-funded employer clients, maintaining continuity of care. The Faircost Optimizer adds an integrated tool to manage out-of-network claims and limit balance-billing exposure. Management describes the combination of enhanced network access and cost-containment tools as reinforcing Marpai's path to scalable growth and previously guided profitability targets for 2026.

Loading...
Loading translation...

Positive

  • Renewed Aetna Signature Administrator PPO network access
  • Integrated Aetna Faircost Optimizer for out-of-network cost control
  • Robust sales cycle with new clients effective Jan 1, 2026

Negative

  • None.

Renews Aetna Signature Administrator Network Agreement and Enhances Cost Containment with Faircost Optimizer

TAMPA, Fla., Dec. 1, 2025 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Pharmacy Benefit Management (PBM) and Third-Party Administration (TPA) services, announced significant positive momentum heading into the new year, highlighted by a better-than-expected sales cycle for 2026 and the renewal of its critical network access agreement with Aetna.

The Company reports a robust sales cycle, securing a volume of new clients for January 1, 2026, that surpasses internal expectations, reinforcing its path to scalable growth and previously guided profitability targets.

In a move that solidifies its premier network offering, Marpai has successfully renewed its agreement to access the Aetna Signature Administrator (ASA) PPO network. This renewal ensures that Marpai's self-funded employer clients and their members continue to receive broad, national access to Aetna's extensive network of high-quality providers, maintaining continuity of care and competitive network discounts.

Furthermore, Marpai will now offer the Aetna Faircost Optimizer as an integrated cost management tool for benefit plan administrators. The Faircost Optimizer is designed to help plan sponsors effectively manage their out-of-network claims costs, which are often unpredictable and challenging to control. By leveraging this sophisticated tool, Marpai enhances its ability to deliver superior cost containment, providing maximum savings on non-contracted claims and protecting self-funded plans from excessive balance billing.

Damien Lamendola, Chief Executive Officer of Marpai, stated, "Our strategy of combining innovative technology with best-in-class network access is clearly resonating in the market. The success of our 2026 sales cycle, coupled with the important renewal of the Aetna Signature Administrator network agreement, sets a strong foundation for the year ahead. The addition of Aetna's Faircost Optimizer transforms our offering, handing clients a powerful lever to slash out-of-network liabilities and drive significant plan savings."

About Marpai, Inc.

Marpai, Inc. (OTCQX: MRAI) is a technology platform company which operates subsidiaries that provide TPA, PBM and value-oriented health plan services to employers that directly pay for employee health benefits. Primarily competing in the $150 billion TPA sector serving self-funded employer health plans representing over $1.5 trillion in annual claims. Through its Marpai Saves initiative, the Company works to deliver the healthiest member population for the health plan budget. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna and all TPA services. For more information, visit www.marpaihealth.com, the content of which is not incorporated by reference into this press release. Investors are invited to visit https://ir.marpaihealth.com.

Forward-Looking Statement Disclaimer

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "guidance," "may," "can," "could", "will", "potential", "should," "goal" and variations of these words or similar expressions. For example, the Company is using forward-looking statements when it discusses the current sales rate for Q1 2026 and the impact of the Aetna Signature Network and Faircost Optimizer program. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai's current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai's current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.

More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai's filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.

(PRNewsfoto/Marpai)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/marpai-announces-2026-momentum-and-key-partnership-expansion-302629508.html

SOURCE Marpai

FAQ

What did Marpai (MRAI) announce on December 1, 2025 about Aetna network access?

Marpai renewed access to the Aetna Signature Administrator (ASA) PPO network, preserving national provider coverage for its self-funded clients.

How will the Aetna Faircost Optimizer affect Marpai (MRAI) clients in 2026?

The Faircost Optimizer will be offered as an integrated tool to help manage out-of-network claims and reduce balance-billing exposure.

What timing did Marpai (MRAI) give for new client starts from its 2026 sales cycle?

Marpai said it secured a volume of new clients scheduled to begin on January 1, 2026.

Does the December 1, 2025 announcement change Marpai's profitability outlook for 2026?

Marpai stated the sales momentum and network renewal reinforce its path to previously guided profitability targets for 2026.

Will Marpai's self-funded employer clients keep current provider access after the renewal?

Yes; the ASA renewal maintains broad, national access to Aetna's provider network for Marpai clients.
Marpai Inc

OTC:MRAI

MRAI Rankings

MRAI Latest News

MRAI Latest SEC Filings

MRAI Stock Data

6.70M
12.09M
49.81%
10.8%
0.16%
Healthcare Plans
Services-misc Health & Allied Services, Nec
Link
United States
TAMPA